Lombard Medical Limited
Natalie Hayes is an experienced professional who has held various key roles in clinical, regulatory, and corporate affairs within the medical industry. Currently serving as Senior Vice President at Lombard Medical Limited, Natalie has also held positions such as Chief Medical Officer, Medical Director, and Director of Clinical Affairs at companies like Ablatus Therapeutics, Selentus Science Limited, and Covalon Technologies Ltd. With a strong educational background in medicine and law from reputable institutions such as the University of Leicester and BPP Law School, Natalie is a valuable asset in the healthcare sector.
This person is not in any teams
Lombard Medical Limited
Lombard Medical Limited is an Oxfordshire, UK-based medical device company focused on the market for minimally invasive treatment of aortic aneurysms (TAA/AAA). The Company has global regulatory approval for Aorfix™, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. Lombard also manufactures the Altura™ stent graft, an innovative ultra-low profile device with a unique easy to use design that lends itself to day case EVAR, and which has been widely used in the repair of other failing EVAR devices. Lombard now also supplies the Minos™ ultra-low profile AAA stent graft, as well as the low profile Hercules™ TAA system. We continue to innovate and look for ways to enhance and increase the options physicians have to treat their patients.